Abstract
Background
Oxidation is a major degradation pathway in drug products (second only to hydrolysis), motivating mechanistic control strategies that operate at the level of the dosage-form micro-environment and its packaging interface. [1] Moisture uptake by solids can occur readily and can drive hydrolysis, impurity formation, and loss of actives, establishing humidity as a coupled chemical and physical stability stressor in solid dosage forms and nutraceuticals. [2]
Scope
This review synthesizes evidence on:
- Oxidation and peroxide-driven mechanisms,
- Permeability and barrier-controlled micro-environments in packaging and coatings,
- Nutraceutical case studies (omega-3 oils, probiotics, and vitamin C), with emphasis on supply-chain-relevant storage stressors and accelerated testing conditions. [1, 3–6]
Key Findings
- Oxidative chemistry in solids and semi-solids can proceed via radical chain mechanisms with initiation by hydroperoxides (ROOH), common excipient impurities, and via direct hydrogen peroxide reactivity with susceptible functional groups such as tertiary amines and thioethers. [1, 7]
- Packaging barrier performance is coupled to stability in blistered systems, with slower degradation in higher-barrier blisters under modeled humidity conditions such as 40% RH blister-cavity gas phase vs. 70% ambient. [3]
- Moisture-barrier coatings reduce water vapor transmission and tablet weight gain, exemplified by multi-polymer films (HPC/SA/PSAA) lowering WVTR from 180 to 60 g/m²·day and limiting tablet weight gain to 3.5% vs. 10% uncoated at 75% RH. [2]
- Omega-3 supplements are highly vulnerable to oxidation, often exceeding recommended oxidative thresholds due to supply-chain oxygen and temperature exposure. [4, 8]
- Probiotic viability is affected by light, moisture, and oxygen, with nitrogen-filled secondary packaging and multilayer barrier foils significantly improving long-term viability retention. [5, 9]
- Vitamin C stability is pH- and temperature-dependent, with its half-life decreasing significantly under higher pH and elevated temperature conditions. [10, 11]
Implications
Effective oxidative-stress mitigation in nutraceutical supply chains requires co-optimizing:
- Internal sources of oxidants (e.g., excipient peroxides),
- Dosage-form barriers (e.g., coatings and encapsulation),
- External barriers (e.g., packaging and atmosphere control),
All strategies should explicitly manage temperature–humidity excursions under stability programs aligned with ICH accelerated conditions (e.g., 40 °C/75% RH). [1–3, 6]
Keywords
- Micro-environment
- Oxidative degradation
- Hydrolysis
- Water vapor transmission rate
- Blister packaging
- Film coating
- Peroxides
- Omega-3
- Probiotics
- Vitamin C [1–5, 10]
1. Introduction
Nutraceutical dosage forms—tablets, capsules, sachets, and encapsulated oils—are exposed to a stability landscape in which moisture, oxygen, light, and temperature jointly drive chemical aging and functional loss. This is often observed over labeled shelf lives that can extend to two years in omega-3 products. [3–5] Moisture is widely regarded as a critical factor in physical and chemical aging. At the dosage-form level, water uptake can readily occur and can trigger hydrolysis that forms impurities and reduces active content. [2, 3]
Oxidation adds an additional and frequently dominant degradation burden because it is among the most common degradation pathways in pharmaceuticals after hydrolysis. It can be initiated by excipient-derived hydroperoxides and sustained through radical chain propagation in solid or lipid microdomains. [1, 7] In nutraceutical matrices rich in oxidation-prone constituents, such as omega-3 polyunsaturated fatty acids, oxidation can replace unoxidized fatty acids with lipid peroxides, aldehydes, and ketones, impacting quality and biological efficacy. [4, 8]
Within this context, micro-environmental control refers to the deliberate engineering of local chemical and physical conditions experienced by the active ingredient (or live cells). Factors such as local humidity, oxygen availability, and exposure to activating stimuli such as light are managed through formulation design, coating/encapsulation, packaging barriers, and atmosphere management (e.g., vacuum or inert gas). [2, 3, 12, 13]
The aim of this review is to integrate mechanistic evidence on oxidative and moisture-driven degradation with quantitative barrier and stability data. This approach proposes an evidence-based framework for mitigating oxidative stress across nutraceutical supply chains, with emphasis on solid and encapsulated dosage forms where permeability dynamics and micro-environmental evolution are central to shelf-life performance. [1, 3, 4]
Film Coating Techniques
Film coating techniques are commonly categorized as aqueous solvent coating, organic solvent coating, and dry powder coating, reflecting a trade space between process feasibility, safety, and the micro-environmental exposure of sensitive actives during manufacturing. [19]
Organic solvent coating may outperform aqueous coating in speed and uniformity but is being phased out due to flammability, explosivity, toxicity, environmental issues, difficulty controlling residual solvents, and costly recovery systems. These concerns limit its role in industrial micro-environment engineering despite its potential performance advantages. [19]
Aqueous coating is explicitly described as unsuitable for moisture-sensitive APIs, driving the development of dry coating processes (e.g., compression coating, hot-melt coating, electrostatic dry powder coating, and vapor phase deposition). These technologies create effective moisture barrier films while avoiding solvent-driven exposure risks. [17]
Solid-State Reactions, Maillard Chemistry, and the Role of Water
Coating-route chemistry can influence solid-state interactions and discoloration that may correlate with chemical instability. Studies comparing solvent-dependent (aqueous) with solvent-less dry powder coating showed reduced drug–polymer interactions in dry powder coated systems. Free films of ERL with or without drugs exhibited a lower extent of interactions under dry powder coating, indicating that process-route water exposure can significantly affect stability. [20]
Research into color changes reported that tablets coated with aqueous methods showed higher yellowing, attributed to Maillard reactions, than those treated with dry coatings. This reaction peaks in the presence of water and is more pronounced in alkaline than in acidic conditions, suggesting a connection between process moisture, local pH microdomains, and changes in product appearance. [20]
Additives and Permeability Modifiers
Additive levels can impact water vapor permeability in a non-linear manner. For instance, low levels (10% w/w) of titanium dioxide caused slight increases in the water vapor permeability of polyvinyl alcohol films, whereas higher levels (20% w/w) resulted in a sharp increase, highlighting how pigment load can compromise barrier performance by altering film microstructure and diffusion pathways. [17]
Standardized moisture sorption characterization supports the development of predictive permeability models. The USP recommends weighing samples hourly until consecutive measurements show a mass change of less than 0.25%, emphasizing the rigor required for permeability-related determinations. [17]
Peroxide Control Through Excipient Selection
Oxidative stress can be mitigated by limiting internal oxidant reservoirs (e.g., peroxides) introduced by excipients. Kollicoat® IR (PEG-PVA), a grafted copolymer used as a wet binder in tablets, has demonstrated stable peroxide levels under both long-term and accelerated storage conditions. For example, PEG-PVA cast films (100 μm) evaluated at 40 °C/75% RH displayed peroxide levels below 1 mEq/kg after 18 months. In comparison, traditional binders with regular packaging showed peroxide levels exceeding 200 ppm. Such findings highlight the importance of excipient selection in reducing oxidation risks. [18]
Povidone systems with higher peroxide levels (>200 ppm) resulted in significant degradation of sensitive actives like raloxifene (approximately 0.02%). This underscores how reducing peroxide burdens can translate into measurable reductions in oxidation products in peroxide-sensitive APIs. [18]
Case Studies in Nutraceutical Stability
Omega-3 Fatty Acids and Lipid Peroxidation
Fish oils in dietary supplements are highly susceptible to oxidation due to their high content of unsaturated omega-3 fatty acids. Oxidation can lead to a depletion of the active ingredients and the formation of lipid peroxides, aldehydes, and ketones as secondary oxidation products. Monitoring these changes is critical, given the typical two-year shelf life of these products. [4]
A key parameter for oxidation monitoring in omega-3 supplements is the TOTOX index, an indicator of the degree of oxidation. High TOTOX values correlate with reduced biological efficacy of EPA and DHA. Specific thresholds, such as the Codex permissible peroxide (PO) value of 10 meq/kg for edible oils and the GOED recommendation of a PO value of 5 meq/kg or below for fish oils, provide guidance for acceptable product quality. [4]
Market analyses indicate frequent exceedance of recommended oxidation limits, inconsistent delivered doses, and quality issues in omega-3 products. Only a small percentage of fish oil supplements meet or exceed labeled EPA/DHA content, underscoring the need for supply-chain monitoring and robust storage conditions to ensure the product quality over time. [4]
Micro-environmental strategies such as oxygen and temperature control with physical encapsulation can reduce oxidative stress in omega-3 systems. For instance, gel capsules limit lipid exposure to oxygen and light, resulting in lower PV, p-AV, and TOTOX indices compared to liquid forms. Additionally, encapsulated products maintain better sensory qualities, including reduced rancid odor and flavor, compared to unencapsulated counterparts. [8, 21]
Encapsulation efficacy demonstrates measurable benefits. Using a nanofiber system for 5% fish oil significantly reduced oxidation markers under stress conditions, while spray-dried systems showed high encapsulation efficiency (84–90%) and superior oxidative stability when whey protein was utilized as the encapsulating agent. Under accelerated storage conditions, however, oxidation remains a concern, particularly under temperature excursions during the supply chain. [23, 24, 25, 26]
Probiotic Viability Under Environmental Stress
Probiotic stability is primarily impacted by light, moisture, and oxygen exposure, with oxygen playing a critical role in reducing microorganism viability. Oxygen-sensitive bacteria are particularly vulnerable, with toxic metabolites and oxidative damage leading to significant cell death. Packaging and formulation strategies that limit oxygen ingress are essential to maintaining bacterial viability. [27]
Water activity and storage temperature are key factors affecting probiotic shelf-life. Optimal stability is achieved when total water activity remains below 0.2 (ideally below 0.15). Packaging with strong barrier properties, such as multilayer foils, is effective in maintaining high probiotic viability. For example, utilizing multilayer foil within a nitrogen-filled bag maintained viability significantly better compared to single-layer packaging. Additional protections, such as blister packaging, further improved long-term viability. [5, 9]
Encapsulation and immobilization can buffer probiotics from environmental stresses, leading to enhanced thermal stability and longer shelf-life. Freeze-drying resulted in lower initial viability loss compared to spray-drying, underscoring the role of process selection in optimizing storage stability. Modified atmospheres and low-temperature storage further extend probiotic viability, with the longest shelf-life observed under −20 °C storage conditions. [29, 30, 13]
Vitamin Stability
Vitamin C (L-ascorbic acid, ASC) is especially sensitive to micro-environmental pH and temperature, which can drive degradation through acid/base hydrolysis and oxidation. ASC's stability decreases sharply with increasing pH, making pH microdomain control a critical factor for stability. [10]
Specific formulation strategies, such as the use of ASC–sucrose/mannitol eutectics, can increase half-life under specific conditions (e.g., phosphate buffer at pH 7). However, acidic conditions decrease their stabilizing effects due to sucrose degradation. Binding-energy studies provide insights into how excipient chemistry enhances stability via non-covalent interactions. [10]
Thermal stress tests reveal that excipient composition can modulate thermal decomposition thresholds. For example, commercial tablets exhibit no degradation below 150 °C and show stability improvements when paired with protective excipients. However, supply-chain temperature excursions, particularly without air conditioning, can lead to significant vitamin C degradation and potency loss during long-term storage. [31, 11]
Supply Chain Considerations and Stability Logistics
Nutraceutical supply-chain stability strategies often rely on ICH-compliant accelerated stability programs paired with quality assessments. For example, an ICH Q1A(R2)-guided study determined an extrapolated 24-month shelf life for a capsule formulation stored under accelerated conditions (40 °C ± 2 and 75% RH ± 5). Similarly, accelerated testing of a nutraceutical powder revealed no significant organoleptic or microbiological changes, with a calculated shelf life exceeding 4 years. [6, 32]
Packaging design influences stability outcomes under identical storage conditions. For instance, tablets demonstrated greater stability than capsules or sachets under high RH and elevated temperature conditions, and moisture levels were tightly controlled across all forms. Despite this, declines in functional bioactive indices, such as phenolic and flavonoid markers, were observed under high RH storage. [33]
Microbiological assessments further confirm the robustness of such storage strategies. Nutraceutical products showed low total plate counts, with no detection of harmful microbial contaminants (e.g., Salmonella or E. coli), supporting safety under accelerated storage conditions. [33]
Discussion
The results support an integrative model where oxidative stress in solid dosage forms arises from three connected factors:
- Barrier-Controlled Permeant Flux: Packaging and coatings that reduce moisture ingress significantly impact stability, as evidenced by reductions in WVTR and moisture-related degradation in barrier-optimized formulations. [2, 3]
- Formulation Composition: Excipient-induced oxidative stress, such as peroxide-driven degradation, can be mitigated by selecting peroxide-free excipients like PEG-PVA. [1, 18]
- Storage History: Environmental conditions, including light, humidity, and temperature, can overwhelm barriers and accelerate degradation processes, emphasizing the importance of careful supply-chain management. [12, 14]
These mechanistic insights illuminate variability in product stability, such as oxidation in omega-3 supplements driven by oxygen and temperature or probiotic viability determined by moisture and light. [4, 5, 9, 13, 26]
The industrial implications suggest that “micro-environmental control” should encompass defined specifications over barrier performance, excipient selection, and logistics limits on temperature and light exposure. These factors must align with accelerated stability studies and product-specific requirements for effective implementation in supply chain management. [1–3, 6, 11]
Future Perspectives
Advancements in predictive models and monitoring of micro-environmental factors will enhance pharmaceutical and nutraceutical stability. Mechanistic blister modeling, for example, already provides valuable predictions for drug stability over extended periods. Expanding these models to include factors such as light exposure could yield additional insights and improvements for the stability of bioactive compounds. [3, 14]
Strategies to Improve Oxidation Monitoring and Control
A second priority is to move from periodic end-point testing to continuous or frequent monitoring of oxidation-relevant markers across the supply chain, motivated by the need to monitor chemical quality over two-year shelf lives in omega-3 products and by evidence that certification does not guarantee maintenance of quality throughout storage, implying that logistics conditions and monitoring must be coupled. [4, 8]
Finally, future formulation strategies should further integrate internal oxidant suppression with barrier design, leveraging quantified excipient hydroperoxide burdens and demonstrated benefits of peroxide-free binders under accelerated conditions, while maintaining compatibility with coating processes that avoid moisture exposure for moisture-sensitive actives (i.e., considering dry coating approaches when aqueous coating is not appropriate). [1, 17, 18]
Conclusions
Oxidative stress in nutraceutical supply chains is a multi-factor problem driven by the interaction of permeant transport (oxygen and water vapor), internal oxidant reservoirs (hydroperoxides and hydrogen peroxide), and storage stressors (temperature and light), which together define the evolving micro-environment experienced by actives and live microorganisms. [1, 3, 14, 16] The reviewed evidence demonstrates that barrier design can slow degradation (higher-barrier blisters slow degradation and barrier properties correlate with predicted stability), coatings can reduce WVTR and moisture uptake (e.g., 180 to 60 g/m²·day and 3.5% weight gain at 75% RH), and excipient selection can suppress peroxide-driven initiation (PEG-PVA <17 ppm peroxides stable under 40 °C/75% RH), providing multiple orthogonal levers to mitigate oxidation risk. [2, 3, 18]
Case studies reinforce the supply-chain relevance: omega-3 oils are intrinsically vulnerable to oxidation and show frequent market exceedance of oxidative limits and accelerated PV increases at 43 °C, probiotics are strongly affected by light/moisture/oxygen and benefit from nitrogen and multilayer barriers, and vitamin C shows strong pH- and temperature-dependent degradation with large losses under heat excursions—collectively indicating that stability is governed by both intrinsic chemistry and engineered micro-environmental controls. [4, 5, 9–11, 26]
An integrative thesis emerges: mitigating oxidative stress in nutraceutical supply chains requires designing and validating a coupled barrier–formulation–storage system that constrains oxygen and moisture ingress, minimizes internal peroxide reservoirs, and limits temperature and light exposure across distribution, with accelerated stability conditions (e.g., 40 °C/75% RH) serving as a practical quantitative stress test for robustness of the engineered micro-environment. [1, 3, 6, 14]
Conflicts of Interest
The authors declare no conflicts of interest.
Funding
This review received no specific external funding.
